Ion channel regulation by β-secretase BACE1 – enzymatic and non-enzymatic effects beyond Alzheimer's disease

β-site APP-cleaving enzyme 1 (BACE1) has become infamous for its pivotal role in the pathogenesis of Alzheimer's disease (AD). Consequently, BACE1 represents a prime target in drug development. Despite its detrimental involvement in AD, it should be quite obvious that BACE1 is not primarily pre...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Channels (Austin)
Autors principals: Lehnert, Sandra, Hartmann, Stephanie, Hessler, Sabine, Adelsberger, Helmuth, Huth, Tobias, Alzheimer, Christian
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2016
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5001140/
https://ncbi.nlm.nih.gov/pubmed/27253079
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19336950.2016.1196307
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars